Reshma Kewalramani - 10 Feb 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
CEO & President, Director
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
10 Feb 2023
Net transactions value
-$2,779,058
Form type
4
Filing time
14 Feb 2023, 15:58:03 UTC
Previous filing
03 Feb 2023
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $992,481 -3,372 -2.1% $294.33 154,704 10 Feb 2023 Direct
transaction VRTX Common Stock Tax liability $1,786,577 -5,990 -3.9% $298.26 148,714 13 Feb 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.